Article
Publicly Available
Frontmatter
Published/Copyright:
April 30, 2020
Published Online: 2020-04-30
Published in Print: 2020-06-25
©2020 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Editorial
- Advancements in mass spectrometry as a tool for clinical analysis: part II
- Quantitative protein assessment
- Complexity, cost, and content – three important factors for translation of clinical protein mass spectrometry tests, and the case for apolipoprotein C-III proteoform testing
- Vedolizumab quantitation using high-resolution accurate mass-mass spectrometry middle-up protein subunit: method validation
- Development and evaluation of an element-tagged immunoassay coupled with inductively coupled plasma mass spectrometry detection: can we apply the new assay in the clinical laboratory?
- MALDI-MS for the clinic
- Matrix-assisted laser desorption ionisation (MALDI) mass spectrometry (MS): basics and clinical applications
- Clinical use of mass spectrometry (imaging) for hard tissue analysis in abnormal fracture healing
- Cellular resolution in clinical MALDI mass spectrometry imaging: the latest advancements and current challenges
- Bacterial identification by lipid profiling using liquid atmospheric pressure matrix-assisted laser desorption/ionization mass spectrometry
- Clinical application of ’omics technologies
- Individualized metabolomics: opportunities and challenges
- Diagnostic amyloid proteomics: experience of the UK National Amyloidosis Centre
- The “olfactory fingerprint”: can diagnostics be improved by combining canine and digital noses?
- Peptidomic and proteomic analysis of stool for diagnosing IBD and deciphering disease pathogenesis
- The influence of hypoxia on the prostate cancer proteome
- Laboratory automation and kit-based approaches
- Mass spectrometry and total laboratory automation: opportunities and drawbacks
- The pathway through LC-MS method development: in-house or ready-to-use kit-based methods?
- Evaluation of the 25-hydroxy vitamin D assay on a fully automated liquid chromatography mass spectrometry system, the Thermo Scientific Cascadion SM Clinical Analyzer with the Cascadion 25-hydroxy vitamin D assay in a routine clinical laboratory
Articles in the same Issue
- Frontmatter
- Editorial
- Advancements in mass spectrometry as a tool for clinical analysis: part II
- Quantitative protein assessment
- Complexity, cost, and content – three important factors for translation of clinical protein mass spectrometry tests, and the case for apolipoprotein C-III proteoform testing
- Vedolizumab quantitation using high-resolution accurate mass-mass spectrometry middle-up protein subunit: method validation
- Development and evaluation of an element-tagged immunoassay coupled with inductively coupled plasma mass spectrometry detection: can we apply the new assay in the clinical laboratory?
- MALDI-MS for the clinic
- Matrix-assisted laser desorption ionisation (MALDI) mass spectrometry (MS): basics and clinical applications
- Clinical use of mass spectrometry (imaging) for hard tissue analysis in abnormal fracture healing
- Cellular resolution in clinical MALDI mass spectrometry imaging: the latest advancements and current challenges
- Bacterial identification by lipid profiling using liquid atmospheric pressure matrix-assisted laser desorption/ionization mass spectrometry
- Clinical application of ’omics technologies
- Individualized metabolomics: opportunities and challenges
- Diagnostic amyloid proteomics: experience of the UK National Amyloidosis Centre
- The “olfactory fingerprint”: can diagnostics be improved by combining canine and digital noses?
- Peptidomic and proteomic analysis of stool for diagnosing IBD and deciphering disease pathogenesis
- The influence of hypoxia on the prostate cancer proteome
- Laboratory automation and kit-based approaches
- Mass spectrometry and total laboratory automation: opportunities and drawbacks
- The pathway through LC-MS method development: in-house or ready-to-use kit-based methods?
- Evaluation of the 25-hydroxy vitamin D assay on a fully automated liquid chromatography mass spectrometry system, the Thermo Scientific Cascadion SM Clinical Analyzer with the Cascadion 25-hydroxy vitamin D assay in a routine clinical laboratory